Close
Nordic 9Nordic 9

Metellus AG (investor - Private Equity)

Switzerland metellus.ch
See something wrong or missing? Let us know
Offices:Zurich

Metellus AG is a private investment office actively involved in the management of a diverse portfolio of investments in private equity and venture capital

Average round investment:29.1M USD
Average number per year:1.5
Distribution: 2022 (1)2020 (2)
Portfolio companies: Switzerland QuantalRFUnited Kingdom Immune Regulation
Mostly invests in: Switzerland Switzerland (2) Wireless (2)

3 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Metellus AG

Name Criteria
United States Obvious Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Switzerland Schroder Adveq
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Switzerland, United Kingdom
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
United States Adjuvant Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Hong Kong CR-CP Life Science Fund
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Longitude Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States +ND Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Rick Klausner
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Germany Fresenius Medical Care Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Switzerland GF Group
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United Kingdom ALSA Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top